Avextra AG: Avextra Unveils Promising Study Results at Major Pain Congress
Avextra Unveils Promising Study Results at Major Pain Congress New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic ...
Avextra Unveils Promising Study Results at Major Pain Congress
New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic Pain News Release Bensheim, Germany – 13 March 2025 – At its annual congress in ...